Zimbabwe has rejected a major American healthcare agreement worth 367 million US dollars (£272m) spanning five years over the United States' request for sensitive information.
This rejection was revealed following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesman later clarified that the US was demanding access to genetic material for scientific study and commercial purposes while refused to guarantee the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further talks to reach a agreement agreeable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Background
This rejection follows a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were filed about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date agreed to similar agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for medical research with no certainty that the resulting innovations would be available to our population if a new health crisis arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its push of bilateral health agreements were upending systems previously established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future pandemics.
"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how subsequent collaboration could be designed in a manner that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body expressed it recognised the official position, but suggested that negotiations need to persist considering much of the country's Aids initiatives relied on international support.
"If technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group added.
The halted deal emphasises the complex challenges between receiving much-needed foreign assistance and safeguarding local interests in an ever more data-driven world.